NeuMoDx Flu A-B/RSV/SARS-CoV-2 Test Strip

Four respiratory viral infections. One NeuMoDx test.

Ready to tackle challenging upper respiratory pathogens?

With the NeuMoDx FluA/FluB/RSV/SARS-CoV-2 Test Strip you can test for SARS-CoV-2, Influenza A, Influenza B and RSV using only one swab, with more comfort and less stress for patients and lab technicians. Analyze more samples in less time and get efficient results in just over an hour.

Upper respiratory TRACT pathogens SARS-CoV-2, Influenza A, Influenza B and RSV share a variety of similar signs and symptoms, such as cough, fever and fatigue, making distinguishing one from the other even more difficult.

Is it SARS-CoV-2, RSV or influenza?

Upper respiratory TRACT pathogens SARS-CoV-2, Influenza A, Influenza B and RSV share a variety of similar signs and symptoms, such as cough, fever and fatigue, making distinguishing one from the other even more difficult.
Davide Manissero MD
A solution that covers the four main respiratory viral infections in one can be used to get results in the most efficient way, supporting labs during increased testing demands.
Davide Manissero MD, MRCPCH, MSc, DTM&H, Chief Medical Officer, QIAGEN

Monitor new SARS-CoV-2 variant

A highly mutated SARS-CoV-2 variant descending from BA.2 has been reported in the United Kingdom, United States, Denmark, and Israel.*

The new variant, designated BA.2.86, carries 30 additional spike changes compared to the parental BA.2 lineage. Due to the overall reduced genomic surveillance of SARS-CoV-2 it cannot be determined whether the variant is circulating undetected elsewhere.

World Health Organization has classified BA.2.86 as a variant under monitoring as of 17 August. Additionally, the European Centre for Disease Prevention and Control (ECDC) classified all XBB.1.5-like lineages with additional spike protein change F456L as variants of interest. This includes lineages EG.5, FL.1.5.1, XBB.1.16.6, and FE.1.

You can continue to monitor all new variants of interest with NeuMoDx 96 and 288, QIAstat-Dx Respiratory SARS-CoV-2 Panel and QIAstat-Dx SARS-CoV-2/Flu A/B/RSV.

* Source: GISAID EpiCoV, Medical Affairs

Stay up to date on our continuous surveillance assessing the impact of mutations on assay sensitivity
Learn more

Discover the right solution for the right patient needs

For low-risk patients with high-volume testing

For low-risk patients with high-volume testing

  • True random access
  • High volume testing
  • Fully automated, easy to use, real time PCR

QIAstat-Dx: For complex and high-risk patients that require urgent care

  • Get results for 23 pathogens in about an hour
  • Support timely clinical decision-making and rapid therapeutic intervention
  • Simple from start to finish, with UTM or dry swab samples
For low-risk patients with high-volume testing
QIAstat-Dx is your answer to rapid, comprehensive respiratory testing. With QIAstat-Dx

Learn more about the QIAstat-Dx Respiratory SARS-CoV-2 Panel

QIAstat-Dx is your answer to rapid, comprehensive respiratory testing. With QIAstat-Dx, you get results for 23 common respiratory viruses and bacteria, including SARS-CoV-2, influenza and RSV, all in about an hour. Learn how the QIAstat-Dx Respiratory SARS-CoV-2 Panel can change the way you diagnose patients this respiratory season and beyond.

Learn more about QIAstat-Dx

NeuMoDx FluA/FluB/RSV/SARS-CoV-2 Test Strip

The NeuMoDx FluA/FluB/RSV/SARS-CoV-2 Test Strip simultaneously detects and differentiates the two most common strains of influenza (A and B), RSV and SARS-CoV-2 from individuals suspected by a health care provider of respiratory viral infection consistent with COVID-19.

The NeuMoDx FluA/FluB/RSV/SARS-CoV-2 Test Strip simultaneously detects and differentiates the two most common strains of influenza (A and B), RSV and SARS-CoV-2 from individuals suspected by a health care provider of respiratory viral infection consistent with COVID-19.